Discontinued — last reported Q4 '25

Operating Expenses

Variable Lease Cost

Vertex Pharmaceuticals Variable Lease Cost remained flat by 0.0% to $12.53M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 14.9%, from $10.90M to $12.53M. Over 2 years (FY 2023 to FY 2025), Variable Lease Cost shows an upward trend with a 6.0% CAGR.

Analysis

StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2019
Last reportedQ4 2025

How to read this metric

An increase suggests higher utilization of leased assets, which may correlate with increased production or sales volume.

Detailed definition

This metric captures lease payments that are not fixed but fluctuate based on usage, performance, or other indices. Unli...

Peer comparison

Reported as 'Variable Lease Payments' in the lease disclosure notes of most large-cap industrial companies.

Metric ID: is_wmt_variable_lease_cost

Historical Data

3 years
 FY'23FY'24FY'25
Value$44.60M$43.60M$50.10M
YoY Change—-2.2%+14.9%
Range$43.60M – $50.10M
CAGR+6.0%
Avg YoY Growth+6.3%
Median YoY Growth+6.3%

Frequently Asked Questions

What is Vertex Pharmaceuticals's variable lease cost?
Vertex Pharmaceuticals (VRTX) reported variable lease cost of $12.53M in Q4 2025.
How has Vertex Pharmaceuticals's variable lease cost changed year-over-year?
Vertex Pharmaceuticals's variable lease cost increased by 14.9% year-over-year, from $10.90M to $12.53M.
What is the long-term trend for Vertex Pharmaceuticals's variable lease cost?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's variable lease cost has grown at a 6.0% compound annual growth rate (CAGR), from $44.60M to $50.10M.
What does variable lease cost mean?
Lease expenses that change based on usage or other performance-based factors.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.